$211 Million is the total value of Blue Water Life Science Advisors, LP's 10 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 69.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NTRA | Buy | NATERA INC | $45,886,000 | -32.0% | 1,127,981 | +56.2% | 21.78% | +5.5% |
| GH | Buy | GUARDANT HEALTH INC | $43,814,000 | +12.1% | 661,445 | +69.2% | 20.79% | +73.8% |
| CDNA | Buy | CAREDX INC | $37,897,000 | -1.4% | 1,024,515 | +21.2% | 17.98% | +53.0% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $24,206,000 | – | 2,660,000 | +100.0% | 11.49% | – |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $22,954,000 | -12.4% | 2,088,668 | +22.1% | 10.89% | +36.0% |
| TXG | New | 10X GENOMICS INC | $16,121,000 | – | 211,917 | +100.0% | 7.65% | – |
| Buy | SOMALOGIC INC | $7,957,000 | +70.5% | 992,086 | +147.4% | 3.78% | +164.4% | |
| Buy | GINKGO BIOWORKS HOLDINGS INC | $7,180,000 | -50.1% | 1,781,684 | +3.0% | 3.41% | -22.5% | |
| OLK | New | OLINK HLDG ABsponsored ads | $3,716,000 | – | 210,439 | +100.0% | 1.76% | – |
| PEAR THERAPEUTICS INC | $983,000 | -18.6% | 194,686 | 0.0% | 0.47% | +26.6% | ||
| Exit | BETTER THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.14% | – | |
| DHR | Exit | DANAHER CORPORATION | $0 | – | -31,400 | -100.0% | -3.16% | – |
| AVTR | Exit | AVANTOR INC | $0 | – | -410,270 | -100.0% | -5.29% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -168,150 | -100.0% | -8.21% | – |
| TECH | Exit | BIO-TECHNE CORP | $0 | – | -54,711 | -100.0% | -8.66% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -78,300 | -100.0% | -15.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NATERA INC | 12 | Q3 2023 | 33.3% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 21.3% |
| AKOYA BIOSCIENCES INC | 8 | Q3 2023 | 23.4% |
| ADAPTIVE BIOTECHNOLOGIES COR | 8 | Q3 2023 | 17.7% |
| CAREDX INC | 7 | Q2 2022 | 19.0% |
| THERMO FISHER SCIENTIFIC INC | 5 | Q4 2021 | 16.0% |
| MAXCYTE INC | 5 | Q3 2023 | 11.8% |
| BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
| SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
| CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-18 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.